Covid-19

Thumbnail for Pfizer–BioNTech’s Omicron- adapted COVID-19 vaccine receives CHMP recommendation for EU market

27 September 2024

Pfizer–BioNTech’s Omicron- adapted COVID-19 vaccine receives CHMP recommendation for EU market

Thumbnail for Botswana launches pathogen surveillance program with Ginkgo Bioworks

12 September 2024

Botswana launches pathogen surveillance program with Ginkgo Bioworks

Thumbnail for Moderna’s updated COVID-19 vaccine gets approval in Japan

27 August 2024

Moderna’s updated COVID-19 vaccine gets approval in Japan

Thumbnail for EAC conducts rapid response simulation exercises to prepare for disease outbreaks

4 July 2024

EAC conducts rapid response simulation exercises to prepare for disease outbreaks

Thumbnail for FDA recommends updated COVID-19 vaccines targeting JN.1variant

7 June 2024

FDA recommends updated COVID-19 vaccines targeting JN.1variant

Thumbnail for AstraZeneca withdraws COVID Vaccine globally

9 May 2024

AstraZeneca withdraws COVID Vaccine globally

Thumbnail for Moderna posts US$ 1.2 billion net loss in Q1 2024 amid vaccine sales decline

7 May 2024

Moderna posts US$ 1.2 billion net loss in Q1 2024 amid vaccine sales decline

Thumbnail for Pfizer’s net income drops 44% in Q1 2024 amid declining COVID-19 revenue

7 May 2024

Pfizer’s net income drops 44% in Q1 2024 amid declining COVID-19 revenue

Thumbnail for AstraZeneca acknowledges rare blood clot risk in COVID-19 vaccine

3 May 2024

AstraZeneca acknowledges rare blood clot risk in COVID-19 vaccine

Thumbnail for WHO launches CoViNet: A Global Network to combat Coronaviruses

28 March 2024

WHO launches CoViNet: A Global Network to combat Coronaviruses